Advertisement

Springer Seminars in Immunopathology

, Volume 26, Issue 4, pp 425–432 | Cite as

Natural serum IgM maintains immunological homeostasis and prevents autoimmunity

  • Jessica J. Manson
  • Claudia Mauri
  • Michael R. EhrensteinEmail author
Original Article

Abstract

Natural (i.e. low-affinity, preimmune) IgM has a wide range of actions in the immune system. That IgM is important in defence against infection has been recognised for many years but recently, due to the generation of mouse models specifically deficient in serum IgM, other functions of serum IgM have been revealed. The participation of natural IgM in autoimmunity has been a subject of speculation for some time, but there is recent definitive evidence that demonstrates its protective role. This review focuses on these new areas of research, which also show that many pathologies not normally recognised as having an immunological basis are modulated by serum IgM.

Keywords

Antibodies B lymphocyte development Apoptosis Phosphatidylcholine 

References

  1. 1.
    Brandlein S, Pohle T, Ruoff N, et al (2003) Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans. Cancer Res 63:7995Google Scholar
  2. 2.
    Bos NA, Meeuwsen CG, Hooijkaas H, et al (1987) Early development of Ig-secreting cells in young of germ-free BALB/c mice fed a chemically defined ultrafiltered diet. Cell Immunol 105:235Google Scholar
  3. 3.
    Haury M, Sundblad A, Grandien A, et al (1997) The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 27:1557Google Scholar
  4. 4.
    Lydyard PM, Quartey-Papafio R, Broker B, et al (1990) The antibody repertoire of early human B cells. I. High frequency of autoreactivity and polyreactivity. Scand J Immunol 31:33Google Scholar
  5. 5.
    Hardy RR, Carmack CE, Li YS, et al (1994) Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol Rev 137:91Google Scholar
  6. 6.
    Kantor AB, Herzenberg LA (1993) Origin of murine B cell lineages. Annu Rev Immunol 11:501Google Scholar
  7. 7.
    Casali P, Notkins AL (1989) CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 10:364Google Scholar
  8. 8.
    Boes M, Esau C, Fischer MB, et al (1998) Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 160:4776Google Scholar
  9. 9.
    Ehrenstein MR, O’Keefe TL, Davies SL, et al (1998) Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 95:10089Google Scholar
  10. 10.
    Boes M, Prodeus AP, Schmidt T, et al (1998) A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188:2381Google Scholar
  11. 11.
    Brown JS, Hussell T, Gilliland SM, et al (2002) The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 99:16969Google Scholar
  12. 12.
    Bruggemann M, Rajewsky K (1982) Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal antihapten antibodies of various isotypes. Cell Immunol 71:365Google Scholar
  13. 13.
    Lehner P, Hutchings P, Lydyard PM, et al (1983) II. IgM-mediated enhancement: dependency on antigen dose, T-cell requirement and lack of evidence for an idiotype-related mechanism. Immunology 50:503Google Scholar
  14. 14.
    Baker N, Ehrenstein MR (2002) Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM. J Immunol 169:6686Google Scholar
  15. 15.
    Cariappa A, Tang M, Parng C, et al (2001) The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14:603Google Scholar
  16. 16.
    Okamura M, Kanayama Y, Amastu K, et al (1993) Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology. Ann Rheum Dis 52:14Google Scholar
  17. 17.
    Ehrenstein MR, Katz DR, Griffiths MH, et al (1995) Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int 48:705Google Scholar
  18. 18.
    Mason LJ, Ravirajan CT, Latchman DS, et al (2001) A human anti-dsDNA monoclonal antibody caused hyaline thrombi formation in kidneys of ‘leaky’ SCID mice. Clin Exp Immunol 126:137Google Scholar
  19. 19.
    Tsao BP, Ohnishi K, Cheroutre H, et al (1992) Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol 149:350Google Scholar
  20. 20.
    Ito MR, Terasaki S, Kondo E, et al (2000) Experimental lupus nephritis in severe combined immunodeficient (SCID) mice: remodelling of the glomerular lesions by bystander IgM antibodies. Clin Exp Immunol 119:340Google Scholar
  21. 21.
    Inoue T, Okumura Y, Shirama M, et al (1986) Selective partial IgM deficiency: functional assessment of T and B lymphocytes in vitro. J Clin Immunol 6:130Google Scholar
  22. 22.
    Ohno T, Inaba M, Kuribayashi K, et al (1987) Selective IgM deficiency in adults: phenotypically and functionally altered profiles of peripheral blood lymphocytes. Clin Exp Immunol 68:630Google Scholar
  23. 23.
    Boes M, Schmidt T, Linkemann K, et al (2000) Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA 97:1184Google Scholar
  24. 24.
    Ehrenstein MR, Cook HT, Neuberger MS (2000) Deficiency in serum immunoglobulin (Ig) M predisposes to development of IgG autoantibodies. J Exp Med 191:1253Google Scholar
  25. 25.
    Diamond B, Scharff MD (1984) Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci USA 81:5841Google Scholar
  26. 26.
    Zeng D, Lee MK, Tung J, et al (2000) Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 164:5000Google Scholar
  27. 27.
    Atencio S, Amano H, Izui S, et al (2004) Separation of the New Zealand black genetic contribution to lupus from New Zealand black determined expansions of marginal zone B and B1a cells. J Immunol 172:4159Google Scholar
  28. 28.
    Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317Google Scholar
  29. 29.
    Amoura Z, Chabre H, Koutouzov S, et al (1994) Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 37:1684Google Scholar
  30. 30.
    Simon JA, Cabiedes J, Ortiz E, et al (2004) Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker. Rheumatology 43:220Google Scholar
  31. 31.
    Botto M, Dell’Agnola C, Bygrave AE, et al (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56Google Scholar
  32. 32.
    Kim SJ, Gershov D, Ma X, et al (2002) I-PLA2 Activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196:655Google Scholar
  33. 33.
    Varambally S, Bar-Dayan Y, Bayry J, et al (2004) Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells. Int Immunol 16:517Google Scholar
  34. 34.
    Shaw PX, Goodyear CS, Chang MK, et al (2003) The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol 170:6151Google Scholar
  35. 35.
    Hughes GR (1993) The antiphospholipid syndrome: ten years on. Lancet 342:341Google Scholar
  36. 36.
    Rieben R, Roos A, Muizert Y, et al (1999) Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 93:942Google Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Jessica J. Manson
    • 1
  • Claudia Mauri
    • 1
  • Michael R. Ehrenstein
    • 1
    Email author
  1. 1.Department of RheumatologyUniversity College LondonLondonUK

Personalised recommendations